About

Duncan Paterson, Senior Director – Device Development at AstraZeneca, has over 20 years of technical leadership experience in the development of inhalation and parenteral devices for pharmaceutical combination products. Currently a Senior Director with AstraZeneca, previously with Novartis and Nektar Therapeutics, Mr Paterson leads device development and chemistry, manufacturing and controls project teams across all stages of the product lifecycle, as well as strategic technology and sustainability related initiatives and working groups. He also co-leads the Sustainability Sub-Team of the SC Consortium.